Doximity insider files Form 4: 2,000-share conversion and sale under 10b5-1 plan

Rhea-AI Filing Summary

Insider transactions by Doximity director Kira Scherer on 09/02/2025: The filing shows a conversion and concurrent sale resulting in a net decrease of 1,000 shares of Class A common stock beneficially owned by the reporting person. Specifically, 2,000 shares of Class B were converted into Class A and 2,000 Class A shares were sold at $66.57 each, leaving 19,839 shares of Class A beneficially owned after the sale. The report also discloses derivative holdings: the reporting person holds stock options with a $1.54 exercise price (2,000 option rights) granted June 10, 2020, that vested monthly starting March 27, 2020, and substantial Class B common stock holdings (468,700 shares) that are convertible into Class A under the company charter.

Positive

• Sale executed under a Rule 10b5-1 trading plan, indicating a pre-established, compliance-oriented transaction
• Retains significant Class B convertible stake (468,700 shares), maintaining long-term alignment with company equity

Negative

• Net decrease in Class A beneficial ownership to 19,839 shares following the reported conversion and sale
• Disposition of 2,000 shares at $66.57 reduced immediate insider-held Class A liquidity

Insights

Securities Analyst

TL;DR: Director executed a conversion and Rule 10b5-1 sale, modest net share reduction; retains large convertible Class B stake.

The reported transactions are routine for insiders: a conversion of Class B into Class A followed by an automatic sale under a previously adopted Rule 10b5-1 plan, producing proceeds at $66.57 per share for 2,000 shares. Post-transaction beneficial ownership in Class A is 19,839 shares while Class B holdings remain material at 468,700 shares and are convertible into Class A under the charter. The director also retains in-the-money options with a $1.54 exercise price originally granted in 2020 that continue to vest per the stated schedule. These facts suggest portfolio rebalancing or liquidity actions rather than operational changes at the issuer.

Corporate Governance Expert

TL;DR: Transaction follows governance-compliant plan (10b5-1); no indication of extraordinary corporate event.

The filing explicitly notes the sale occurred automatically under a Rule 10b5-1 trading plan adopted November 12, 2024, which provides affirmative defense to insider trading allegations when properly implemented. Conversion mechanics and conversion triggers are described in the charter language included in the explanations. The presence of sizable Class B convertible holdings confirms continued alignment with pre-IPO/dual-class governance structures. No amendments or other unusual filings accompany this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wampler Kira Scherer

(Last) (First) (Middle)

C/O DOXIMITY, INC.

500 THIRD STREET

(Street)

SAN FRANCISCO CA 94107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/02/2025		C(1)		2,000	A	(1)	21,839	D
Class A Common Stock	09/02/2025		S(2)		2,000	D	$66.57	19,839	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.54	09/02/2025		M			2,000	(3)	06/09/2030	Class B Common Stock(4)	2,000	$0	468,700	D
Class B Common Stock	(4)	09/02/2025		M		2,000		(4)	(4)	Class A Common Stock	2,000	$0	2,000	D
Class B Common Stock	(4)	09/02/2025		C			2,000	(4)	(4)	Class A Common Stock	2,000	$0	0	D

Explanation of Responses:

1. Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.

2. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2024.

3. The stock option vested in 36 equal monthly installments after March 27, 2020, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on June 10, 2020.

4. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.

Remarks:

	/s/ Anna Bryson, Attorney-in-Fact	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did DOCS director Kira Scherer report on the Form 4?

The Form 4 reports conversion of 2,000 Class B shares into Class A and the sale of 2,000 Class A shares at $66.57 on 09/02/2025, and derivative holdings including 2,000 stock option rights with a $1.54 exercise price.

Was the sale of DOCS shares done under an insider trading plan?

Yes. The filing states the sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted November 12, 2024.

How many DOCS shares does the reporting person beneficially own after the transactions?

After the reported transactions, the reporting person beneficially owns 19,839 shares of Class A common stock and 468,700 shares of Class B common stock (convertible into Class A under charter terms).

What are the terms of the reported stock option?

The option has a $1.54 exercise price, represents 2,000 option rights, was granted June 10, 2020, and vested in 36 monthly installments after March 27, 2020, subject to continued service.

Did the Form 4 disclose any amendments or unusual events?

No. The Form 4 indicates it is not an amendment and contains explanatory charter conversion language and trading-plan disclosure, with no other amendments or extraordinary events reported.